Alkahest, Inc

Alkahest, Inc is a clinical stage biopharmaceutical company based in San Carlos, CA, specializing in the development of transformative therapies for neurodegenerative and age-related diseases. With a deep understanding of the plasma proteome in aging and disease, Alkahest harnesses the power of chronokines, proteins that increase or decrease with age, to create groundbreaking therapeutics that halt or reverse the harmful effects of aging in critical diseases such as Alzheimer's, Parkinson's, and Age-related Macular Degeneration (AMD).

Through their unique approach, Alkahest develops clinical candidates that modulate key circulating chronokines to promote innate restorative biological processes or inhibit pathological degenerative processes. Their therapeutics range from traditional pharmaceutical modalities to highly selected and refined plasma fractions, targeting a wide range of age-related disease mechanisms with precision. With a focus on critical diseases of aging, Alkahest is dedicated to advancing the field of plasma therapies and improving the lives of patients affected by these debilitating conditions.

Generated from the website